Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

867 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Antibodies to mutated citrullinated vimentin for diagnosing rheumatoid arthritis in anti-CCP-negative patients and for monitoring infliximab therapy.
Nicaise Roland P, Grootenboer Mignot S, Bruns A, Hurtado M, Palazzo E, Hayem G, Dieudé P, Meyer O, Chollet Martin S. Nicaise Roland P, et al. Among authors: meyer o. Arthritis Res Ther. 2008;10(6):R142. doi: 10.1186/ar2570. Epub 2008 Dec 10. Arthritis Res Ther. 2008. PMID: 19077182 Free PMC article. Clinical Trial.
Prospective cohort study of effects of infliximab on rheumatoid factor, anti-cyclic citrullinated peptide antibodies and antinuclear antibodies in patients with long-standing rheumatoid arthritis.
Bruns A, Nicaise-Roland P, Hayem G, Palazzo E, Dieudé P, Grootenboer-Mignot S, Chollet-Martin S, Meyer O. Bruns A, et al. Among authors: meyer o. Joint Bone Spine. 2009 May;76(3):248-53. doi: 10.1016/j.jbspin.2008.09.010. Epub 2009 Feb 8. Joint Bone Spine. 2009. PMID: 19208451
Autoantibodies to citrullinated fibrinogen compared with anti-MCV and anti-CCP2 antibodies in diagnosing rheumatoid arthritis at an early stage: data from the French ESPOIR cohort.
Nicaise-Roland P, Nogueira L, Demattei C, de Chaisemartin L, Rincheval N, Cornillet M, Grootenboer-Mignot S, Dieudé P, Dougados M, Cantagrel A, Meyer O, Serre G, Chollet-Martin S. Nicaise-Roland P, et al. Among authors: meyer o. Ann Rheum Dis. 2013 Mar;72(3):357-62. doi: 10.1136/annrheumdis-2011-201056. Epub 2012 May 12. Ann Rheum Dis. 2013. PMID: 22580581
Body mass index influences the response to infliximab in ankylosing spondylitis.
Ottaviani S, Allanore Y, Tubach F, Forien M, Gardette A, Pasquet B, Palazzo E, Meunier M, Hayem G, Job-Deslandre C, Kahan A, Meyer O, Dieudé P. Ottaviani S, et al. Among authors: meyer o. Arthritis Res Ther. 2012 May 14;14(3):R115. doi: 10.1186/ar3841. Arthritis Res Ther. 2012. PMID: 22584116 Free PMC article.
Intramedullary tuberculoma during infliximab therapy.
Ottaviani S, Meyer O, Dieudé P. Ottaviani S, et al. Among authors: meyer o. Rheumatology (Oxford). 2010 Jan;49(1):42. doi: 10.1093/rheumatology/kep267. Epub 2009 Sep 4. Rheumatology (Oxford). 2010. PMID: 19734294 No abstract available.
867 results